与PPAR相关基因在慢性心力衰竭中的作用:来自大量人群的证据
Zun-Ping Ke1, Wen-Qi Tao2, Gang Zhao3
1Department of Geriatrics, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
BMC cardiovascular disorders
|November 10, 2023
概括
过氧体增殖器激活受体 (PPAR) 信号基因与慢性心力衰竭 (CHF) 有关. ACADM,PPARG和CPT2被确定为CHF病变发生的关键基因和潜在的治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 基因组学就是基因组学.
背景情况:
- 在慢性心力衰竭 (CHF) 病变发生过程中,氧酶增殖器激活受体 (PPAR) 信号的作用尚不清楚.
- 研究PPAR相关基因为心力衰竭机制提供了潜在的见解.
研究的目的:
- 阐明PPAR相关基因在慢性心力衰竭 (CHF) 的发展和进展中的重要性.
- 确定PPAR信号通路中的关键基因,这些基因可以作为CHF的治疗点.
主要方法:
- 使用了基因表达综合 (GEO) 数据库 (GSE57338) 中的基因表达数据,用于CHF样本.
- 为126个PPAR相关基因构建了一个蛋白质-蛋白质相互作用网络.
- 进行基因本体学和基因和基因组的京都百科全书 (KEGG) 分析,以及免疫透分析.
主要成果:
- 与PPAR相关的基因参与脂质代谢,营养反应和血管过程.
- ACADM,PPARG和CPT2被确定为心力衰竭 (HF) 发病过程中的中心分子.
- 这些基因可能会影响中性粒细胞和M2巨细胞的透,影响CHF机制.
结论:
- 与PPAR相关的基因在心血管衰竭的发展中起着重要作用.
- ACADM,PPARG和CPT2代表了未来对CHF患者临床干预的有希望的目标.
相关概念视频
Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure I: Introduction
14
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
14
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
Transducer Mechanism: Nuclear Receptors
1.4K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.4K
Genome-wide Association Studies-GWAS
13.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.5K


